Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 29, 2018

SELL
$18.89 - $20.49 $191,355 - $207,563
-10,130 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$18.13 - $19.4 $58,868 - $62,991
-3,247 Reduced 24.27%
10,130 $190,000
Q2 2017

Aug 16, 2017

BUY
N/A
13,377
13,377 $279,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.